Iteos Therapeutics Inc
NASDAQ:ITOS

Watchlist Manager
Iteos Therapeutics Inc Logo
Iteos Therapeutics Inc
NASDAQ:ITOS
Watchlist
Price: 7.42 USD 2.77% Market Closed
Market Cap: 271.1m USD
Have any thoughts about
Iteos Therapeutics Inc?
Write Note

Wall Street
Price Targets

ITOS Price Targets Summary
Iteos Therapeutics Inc

Wall Street analysts forecast ITOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITOS is 25.5 USD with a low forecast of 16.16 USD and a high forecast of 49.35 USD.

Lowest
Price Target
16.16 USD
118% Upside
Average
Price Target
25.5 USD
244% Upside
Highest
Price Target
49.35 USD
565% Upside

ITOS Last Price Targets
Iteos Therapeutics Inc

The latest public price target was made on Sep 16, 2024 by Christopher Raymond from Raymond James , who expects ITOS stock to rise by 385% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Christopher Raymond
Raymond James
36 USD
Upside 385%
3 months ago
Sep 16, 2024
Piper Sandler Reiterates Overweight Rating on iTeos Therapeutics (ITOS)
StreetInsider
Eva Fortea Verdejo
Wells Fargo
31 USD
Upside 318%
4 months ago
Aug 13, 2024
iTeos Therapeutics initiated with an Overweight at Wells Fargo
TheFly
Swayampakula Ramakanth
H.C. Wainwright
46 USD
Upside 520%
7 months ago
May 13, 2024
iTeos Therapeutics price target raised to $46 from $44 at H.C. Wainwright
TheFly
Christopher Raymond
Raymond James
Price Target 36 USD
Upside/Downside 385%
View Source
Eva Fortea Verdejo
Wells Fargo
Price Target 31 USD
Upside/Downside 318%
View Source
Swayampakula Ramakanth
H.C. Wainwright
Price Target 46 USD
Upside/Downside 520%
View Source
Iteos Therapeutics Inc Competitors:
Price Targets
ABBV
Abbvie Inc
20% Upside
FOLD
Amicus Therapeutics Inc
85% Upside
BIOCON
Biocon Ltd
4% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
30% Upside
SPRO
Spero Therapeutics Inc
434% Upside
9926
Akeso Inc
26% Upside
CDTX
Cidara Therapeutics Inc
34% Upside
ACLX
Arcellx Inc
57% Upside

Revenue
Forecast

Revenue Estimate
Iteos Therapeutics Inc

The compound annual growth rate of Iteos Therapeutics Inc's revenue for the next 4 years is 75%.

N/A
Past Growth
75%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Iteos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Iteos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ITOS's stock price target?
Price Target
25.5 USD

According to Wall Street analysts, the average 1-year price target for ITOS is 25.5 USD with a low forecast of 16.16 USD and a high forecast of 49.35 USD.

What is Iteos Therapeutics Inc's Revenue forecast?
Projected CAGR
75%

The compound annual growth rate of Iteos Therapeutics Inc's revenue for the next 4 years is 75%.

Back to Top